Evidence map›Paper›PMID 38301092›Full record

ArticleArchives of Iranian medicine2023

Expanding the Molecular Spectrum of

Masoumeh Goleyjani Moghadam, Zohreh Elahi, Mohamad Soveyzi, Sanaz Arzhangi, Shahriar Nafissi, Hossein Najmabadi, Kimia Kahrizi, Zohreh Fattahi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of Iranian medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Masoumeh Goleyjani MoghadamGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.ORCID 0000-0002-1784-5320
Zohreh ElahiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Mohamad SoveyziGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Sanaz ArzhangiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Shahriar NafissiIranian Neuromuscular Research Center (INMRC), Tehran University of Medical Sciences, Tehran, Iran.
Hossein NajmabadiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Kimia KahriziGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Zohreh FattahiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.ORCID 0000-0003-4632-621X
University of Social Welfare and Rehabilitation Sciences · IRIsfahan Fertility and Infertility Center · IRShariati Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Charcot-Marie-Tooth disease type 4G (CMT4G) was first reported in Balkan Gypsies as a myelinopathy starting with progressive distal lower limb weakness, followed by upper limb involvement and prominent distal sensory impairment later in the patient's life. So far, CMT4G has been only reported in European Roma communities with two founder homozygous variants; g.9712G>C and g.11027G>A, located in the 5'-UTR of the

Indexed as

Charcot-Marie-Tooth DiseaseHereditary Sensory and Motor NeuropathyHexokinaseHumansIranMutationPedigreePhenotypeHexokinaseHK1 protein, humanCharcot-Marie-Tooth type 4GHK1 geneWhole exome sequencing

Identifiers

PMID38301092
PMCPMC10685863
OpenAlexW4386105614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.